Sagefield Capital LP

Position in ACLX — Arcellx, Inc.

CIK 1771179 DALLAS, TX

Position in ACLX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,474,437

New position

Shares Held

65,097

first reported quarter

Ownership

0.111%

of shares outstanding

% of Portfolio

0.55%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 14% Shared 86% None 0%

Healthcare · as of Mar 31, 2026

Sagefield Capital LP holds $28,787,528 across 4 Biotechnology names. ACLX ranks #2 (26.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	1,021,016	$14,763,891
2	ACLX	Arcellx, Inc. This page	65,097	$7,474,437
3	APLS	Apellis Pharmaceuticals, Inc.	104,065	$4,186,534
4	DAWN	Day One Biopharmaceuticals, Inc.	110,199	$2,362,666

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,474,437	65,097	—	Shares	Other	2026-05-15
No filing history on record for this holder in this stock.